CN100396278C - 药用微丸丸芯及制备方法 - Google Patents
药用微丸丸芯及制备方法 Download PDFInfo
- Publication number
- CN100396278C CN100396278C CNB2006100526366A CN200610052636A CN100396278C CN 100396278 C CN100396278 C CN 100396278C CN B2006100526366 A CNB2006100526366 A CN B2006100526366A CN 200610052636 A CN200610052636 A CN 200610052636A CN 100396278 C CN100396278 C CN 100396278C
- Authority
- CN
- China
- Prior art keywords
- adhesive
- sucrose
- fine
- major ingredient
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006187 pill Substances 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title description 8
- 229920002472 Starch Polymers 0.000 claims abstract description 37
- 239000008107 starch Substances 0.000 claims abstract description 37
- 235000019698 starch Nutrition 0.000 claims abstract description 37
- 239000000853 adhesive Substances 0.000 claims abstract description 33
- 230000001070 adhesive effect Effects 0.000 claims abstract description 33
- 238000002360 preparation method Methods 0.000 claims abstract description 27
- 238000001035 drying Methods 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims abstract description 13
- 238000005453 pelletization Methods 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000002245 particle Substances 0.000 claims description 33
- 239000008188 pellet Substances 0.000 claims description 24
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 22
- 229930006000 Sucrose Natural products 0.000 claims description 22
- 239000004615 ingredient Substances 0.000 claims description 22
- 229960004793 sucrose Drugs 0.000 claims description 22
- 239000005720 sucrose Substances 0.000 claims description 20
- 238000005469 granulation Methods 0.000 claims description 17
- 230000003179 granulation Effects 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 239000012467 final product Substances 0.000 claims description 10
- 239000004594 Masterbatch (MB) Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002002 slurry Substances 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 229960004016 sucrose syrup Drugs 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract description 10
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract description 10
- 239000008108 microcrystalline cellulose Substances 0.000 abstract description 10
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract description 10
- 238000002156 mixing Methods 0.000 abstract description 2
- 238000007873 sieving Methods 0.000 abstract 1
- -1 polyethylene pyrrole Polymers 0.000 description 19
- 239000008187 granular material Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- 241001597008 Nomeidae Species 0.000 description 10
- 239000003814 drug Substances 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- 238000012856 packing Methods 0.000 description 5
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 4
- 239000004925 Acrylic resin Substances 0.000 description 4
- 229920000178 Acrylic resin Polymers 0.000 description 4
- 239000001856 Ethyl cellulose Substances 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 235000019325 ethyl cellulose Nutrition 0.000 description 4
- 229920001249 ethyl cellulose Polymers 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229920001206 natural gum Polymers 0.000 description 4
- 229960000381 omeprazole Drugs 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 230000009965 odorless effect Effects 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229940080133 omeprazole 20 mg Drugs 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100526366A CN100396278C (zh) | 2006-07-24 | 2006-07-24 | 药用微丸丸芯及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100526366A CN100396278C (zh) | 2006-07-24 | 2006-07-24 | 药用微丸丸芯及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1899266A CN1899266A (zh) | 2007-01-24 |
CN100396278C true CN100396278C (zh) | 2008-06-25 |
Family
ID=37655379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100526366A Active CN100396278C (zh) | 2006-07-24 | 2006-07-24 | 药用微丸丸芯及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100396278C (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101288647B (zh) * | 2007-04-18 | 2012-04-18 | 王雷波 | 一种药用微丸丸芯及其制备方法 |
CN102166361A (zh) * | 2011-04-19 | 2011-08-31 | 杭州高成生物营养技术有限公司 | 一种速崩型微丸丸芯及制备方法 |
CN102327616A (zh) * | 2011-09-05 | 2012-01-25 | 安徽山河药用辅料股份有限公司 | 物理混合法由蔗糖、淀粉制备药用辅料药用微丸丸芯的方法 |
CN103083252A (zh) * | 2013-01-30 | 2013-05-08 | 郑州海缔邦林制药有限公司 | 一种奥美拉唑肠溶微丸及其制作工艺 |
CN105435240A (zh) * | 2014-09-29 | 2016-03-30 | 天津尖峰弗兰德医药科技发展有限公司 | 一种药用微丸丸芯及其制备方法 |
CN105148283A (zh) * | 2015-09-28 | 2015-12-16 | 广东国源国药制药有限公司 | 一种创新药用辅料蔗糖丸芯及其制备方法 |
CN105997893A (zh) * | 2016-07-01 | 2016-10-12 | 张学怀 | 一种高密度微丸丸芯及其制备方法 |
CN106361708A (zh) * | 2016-09-30 | 2017-02-01 | 广州中大南沙科技创新产业园有限公司 | 高密度微丸丸芯及其制备方法 |
CN113694041B (zh) * | 2021-08-27 | 2023-04-28 | 福建太平洋制药有限公司 | 药用蔗糖丸芯的制备工艺 |
CN116549405A (zh) * | 2022-08-20 | 2023-08-08 | 杭州高成生物营养技术有限公司 | 一种低脆碎度的药用糖丸及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4088864A (en) * | 1974-11-18 | 1978-05-09 | Alza Corporation | Process for forming outlet passageways in pills using a laser |
CN1415290A (zh) * | 2002-10-22 | 2003-05-07 | 南京长澳医药科技有限公司 | 双氯芬酸钠缓释胶囊及其制备工艺 |
CN1466945A (zh) * | 2003-06-03 | 2004-01-14 | 天津药物研究院 | 一种含吲达帕胺活性成分的缓释微丸及其制备方法 |
CN1650972A (zh) * | 2004-11-26 | 2005-08-10 | 复旦大学 | 一种含银杏叶提取物的缓释微丸及其制备方法 |
-
2006
- 2006-07-24 CN CNB2006100526366A patent/CN100396278C/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4088864A (en) * | 1974-11-18 | 1978-05-09 | Alza Corporation | Process for forming outlet passageways in pills using a laser |
CN1415290A (zh) * | 2002-10-22 | 2003-05-07 | 南京长澳医药科技有限公司 | 双氯芬酸钠缓释胶囊及其制备工艺 |
CN1466945A (zh) * | 2003-06-03 | 2004-01-14 | 天津药物研究院 | 一种含吲达帕胺活性成分的缓释微丸及其制备方法 |
CN1650972A (zh) * | 2004-11-26 | 2005-08-10 | 复旦大学 | 一种含银杏叶提取物的缓释微丸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1899266A (zh) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100396278C (zh) | 药用微丸丸芯及制备方法 | |
CN103070864B (zh) | 一种瑞格列奈和盐酸二甲双胍药物组合物及其制备方法 | |
CN105832713B (zh) | 一种包含马来酸氟伏沙明的药物组合物及其制备方法 | |
CN103040774B (zh) | 埃索美拉唑镁肠溶片中埃索美拉唑镁的制粒包衣工艺 | |
CN106389369A (zh) | 一种富马酸亚铁叶酸复方薄膜包衣片的制备方法 | |
CN114302712B (zh) | 一种阿昔莫司多单元缓释微丸片及其制备方法 | |
CN101219124A (zh) | 盐酸头孢他美酯分散片及其制备方法 | |
CN110141555A (zh) | 一种恩格列净片及其制备方法 | |
CN102205130A (zh) | 一种低脆碎度药用微丸丸芯及制备方法 | |
CN110354086B (zh) | 一种坎地沙坦酯片剂的制备方法 | |
CN103356498A (zh) | 枸橼酸莫沙必利缓释片 | |
CN102166361A (zh) | 一种速崩型微丸丸芯及制备方法 | |
CN115554255B (zh) | 一种高稳定性的叶酸片及其制备方法 | |
CN102000338B (zh) | 一种二氧化硅小丸及制备方法 | |
CN102772446A (zh) | 抗肿瘤药香菇多糖胶囊工业化生产工艺 | |
CN114469879B (zh) | 一种丁溴东莨菪碱微片及其制备方法和制剂 | |
CN114288259B (zh) | 一种维生素b2的速释制剂及制备方法 | |
CN102379855A (zh) | 格列美脲分散片及其制备方法 | |
EP1541161B1 (en) | Tablet composition containing chinese orthodox medicine extract and process for producing the same | |
CN101224199B (zh) | 茴三硫片及其制备方法 | |
CN102988372A (zh) | 复方阿司匹林片主要辅料的筛选和组成及其制备方法 | |
CN111012750A (zh) | 一种对乙酰氨基酚片及其制备方法 | |
CN102600475B (zh) | 一种药用微丸丸芯及制备方法 | |
CN104740640B (zh) | 一种改善化学药原料粉体学性质的结晶修饰物及其制备方法 | |
CN115245496B (zh) | 一种稳定的依帕司他片的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hangzhou Gaocheng Biotech & Health Co.,Ltd. Assignor: Feng Liping Contract record no.: 2011330000469 Denomination of invention: Medicinal micro pill core and its preparing method Granted publication date: 20080625 License type: Exclusive License Open date: 20070124 Record date: 20110511 |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Feng Liping Inventor before: Feng Liping |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Hangzhou City, Zhejiang province Xihu District 310012 No. 252 Wensanlu Road Weixing building 22 Patentee after: Feng Liping Address before: Hangzhou City, Zhejiang province Xihu District 310012 No. 252 Wensanlu Road Weixing building 22 Patentee before: Feng Liping |
|
TR01 | Transfer of patent right |
Effective date of registration: 20230726 Address after: Room 403, Building 18, Zone 4, Cuiyuan New Village, Xihu District, Hangzhou City, Zhejiang Province, 310000 Patentee after: Feng Liping Patentee after: Hangzhou Gaocheng Biological Nutrition Technology Co.,Ltd. Address before: Hangzhou City, Zhejiang province Xihu District 310012 No. 252 Wensanlu Road Weixing building 22 Patentee before: Feng Liping |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231111 Address after: Room 403, Building 18, Zone 4, Cuiyuan New Village, Xihu District, Hangzhou City, Zhejiang Province, 310000 Patentee after: Feng Liping Address before: Room 403, Building 18, Zone 4, Cuiyuan New Village, Xihu District, Hangzhou City, Zhejiang Province, 310000 Patentee before: Feng Liping Patentee before: Hangzhou Gaocheng Biological Nutrition Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Hangzhou Gaocheng Biotech & Health Co.,Ltd. Assignor: Feng Liping Contract record no.: 2011330000469 Date of cancellation: 20231207 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20070124 Assignee: Hangzhou Gaocheng Biotech & Health Co.,Ltd. Assignor: Feng Liping Contract record no.: X2024980002409 Denomination of invention: Medicinal Pellet Core and Preparation Method Granted publication date: 20080625 License type: Exclusive License Record date: 20240304 |
|
EE01 | Entry into force of recordation of patent licensing contract |